AR037778A1 - Suplementacion mediada por plasmido para el tratamiento de sujetos cronicamente enfermos - Google Patents
Suplementacion mediada por plasmido para el tratamiento de sujetos cronicamente enfermosInfo
- Publication number
- AR037778A1 AR037778A1 ARP020104785A ARP020104785A AR037778A1 AR 037778 A1 AR037778 A1 AR 037778A1 AR P020104785 A ARP020104785 A AR P020104785A AR P020104785 A ARP020104785 A AR P020104785A AR 037778 A1 AR037778 A1 AR 037778A1
- Authority
- AR
- Argentina
- Prior art keywords
- seqid
- nucleic acid
- ghrh
- expression construct
- animal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF] (Somatoliberin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33961001P | 2001-12-11 | 2001-12-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR037778A1 true AR037778A1 (es) | 2004-12-01 |
Family
ID=23329825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020104785A AR037778A1 (es) | 2001-12-11 | 2002-12-10 | Suplementacion mediada por plasmido para el tratamiento de sujetos cronicamente enfermos |
Country Status (11)
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002324909A1 (en) * | 2001-09-07 | 2003-03-24 | Baylor College Of Medicine | Linear dna fragments for gene expression |
WO2003038112A2 (en) * | 2001-10-26 | 2003-05-08 | Baylor College Of Medicine | A composition and method to alter lean body mass and bone properties in a subject |
US7241744B2 (en) * | 2001-12-11 | 2007-07-10 | Baylor College Of Medicine | Treating anemia in subjects by administration of plasmids encoding growth hormone releasing hormone |
MXPA04007638A (es) * | 2002-02-07 | 2004-12-06 | Baylor College Medicine | Desarrollo modificado de la glandula pituitaria en productos de madres animales prenadas, tratadas con terapia de hormona liberadora de hormona del crecimiento. |
CN1662261A (zh) * | 2002-05-28 | 2005-08-31 | 阿德维希斯公司 | 通过多聚-l-谷氨酸(“plg”)系统增加核酸构建体的体内递送 |
AU2003295366B2 (en) * | 2002-11-04 | 2011-11-24 | Advisys, Inc. | Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells |
TW200424214A (en) * | 2003-04-21 | 2004-11-16 | Advisys Inc | Plasmid mediated GHRH supplementation for renal failures |
US7468273B2 (en) | 2003-05-01 | 2008-12-23 | Meial Limited | Canine GHRH gene, polypeptides and methods of use |
WO2005016964A2 (en) * | 2003-08-04 | 2005-02-24 | Advisys, Inc. | Canine specific growth hormone releasing hormone |
NZ553274A (en) * | 2004-07-23 | 2010-02-26 | VGX Pharmaceuticals LLC | Growth hormone releasing hormone enhances the immune response induced by vaccination |
US7846720B2 (en) * | 2005-01-26 | 2010-12-07 | Vgx Pharmaceuticals, Inc. | Optimized high yield synthetic plasmids |
ES2343270T3 (es) | 2005-04-25 | 2010-07-27 | Merial Ltd. | Vacunas contra el virus nipah. |
US7771995B2 (en) | 2005-11-14 | 2010-08-10 | Merial Limited | Plasmid encoding human BMP-7 |
EP3147296A1 (en) | 2005-11-14 | 2017-03-29 | Merial, Inc. | Gene therapy for renal failure |
US8980249B2 (en) | 2010-06-03 | 2015-03-17 | University Of Miami | Agonists of growth hormone releasing hormone as effectors for survival and proliferation of pancreatic islets |
US9216213B2 (en) | 2011-04-20 | 2015-12-22 | Merial, Inc. | Adjuvanted rabies vaccine with improved viscosity profile |
US8993316B2 (en) | 2011-11-16 | 2015-03-31 | Brian P. Hanley | Methods and compositions for gene therapy and GHRH therapy |
US9079974B2 (en) | 2011-12-21 | 2015-07-14 | The University Of Miami | GH-RH analogs with potent agonistic effects |
WO2013138776A1 (en) | 2012-03-16 | 2013-09-19 | Merial Limited | Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g |
WO2014100816A2 (en) | 2012-12-21 | 2014-06-26 | University Of Miami | Ghrh agonists for islet cell transplantation and function and the treatment of diabetes |
WO2014100809A2 (en) | 2012-12-21 | 2014-06-26 | University Of Miami | Ghrh agonists for the treatment of ischemic disorders |
Family Cites Families (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4223019A (en) | 1979-03-30 | 1980-09-16 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
US4228158A (en) * | 1979-03-30 | 1980-10-14 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
US4223021A (en) * | 1979-03-30 | 1980-09-16 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
US4226857A (en) | 1979-03-30 | 1980-10-07 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
US4224316A (en) | 1979-03-30 | 1980-09-23 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
US4228156A (en) * | 1979-03-30 | 1980-10-14 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
US4223020A (en) | 1979-03-30 | 1980-09-16 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
US4410512A (en) | 1981-12-28 | 1983-10-18 | Beckman Instruments, Inc. | Combinations having synergistic pituitary growth hormone releasing activity |
NL8200523A (nl) | 1982-02-11 | 1983-09-01 | Univ Leiden | Werkwijze voor het in vitro transformeren van planteprotoplasten met plasmide-dna. |
US5134120A (en) | 1984-08-03 | 1992-07-28 | Cornell Research Foundation, Inc. | Use of growth hormone to enhance porcine weight gain |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US5036045A (en) * | 1985-09-12 | 1991-07-30 | The University Of Virginia Alumni Patents Foundation | Method for increasing growth hormone secretion |
US4833166A (en) * | 1987-05-01 | 1989-05-23 | Grosvenor Clark E | Growth hormone releasing hormone complementary peptides |
US4839344A (en) * | 1987-06-12 | 1989-06-13 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
USRE33699E (en) | 1987-07-09 | 1991-09-24 | International Minerals & Chemical Corp. | Growth hormone-releasing factor analogs |
FR2622455B1 (fr) * | 1987-11-04 | 1991-07-12 | Agronomique Inst Nat Rech | Application du facteur de stimulation de la secretion de l'hormone de croissance humaine, de ses fragments actifs et des analogues correspondants, pour augmenter la production laitiere et le poids des nouveau-nes chez les mammiferes |
US4952500A (en) * | 1988-02-01 | 1990-08-28 | University Of Georgia Research Foundation, Inc. | Cloning systems for Rhodococcus and related bacteria |
US4956288A (en) | 1988-04-22 | 1990-09-11 | Biogen, Inc. | Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA |
US5023322A (en) | 1988-08-31 | 1991-06-11 | Mta Kutatas-Es Szervezetelemzo Intezete | Analogs of growth hormone releasing factor (GRF) and a method for the preparation thereof |
US5084442A (en) | 1988-09-06 | 1992-01-28 | Hoffmann-La Roche Inc. | Cyclic growth hormone releasing factor analogs and method for the manufacture thereof |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US5302523A (en) | 1989-06-21 | 1994-04-12 | Zeneca Limited | Transformation of plant cells |
US7705215B1 (en) | 1990-04-17 | 2010-04-27 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
US5550318A (en) | 1990-04-17 | 1996-08-27 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
US5137872A (en) | 1989-09-18 | 1992-08-11 | Pitman-Moore, Inc. | Growth hormone-releasing factor analogs |
US5322783A (en) | 1989-10-17 | 1994-06-21 | Pioneer Hi-Bred International, Inc. | Soybean transformation by microparticle bombardment |
US5484956A (en) * | 1990-01-22 | 1996-01-16 | Dekalb Genetics Corporation | Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin |
ZA914983B (en) * | 1990-06-29 | 1992-03-25 | Hoffmann La Roche | His-grf-analogs |
US5486505A (en) | 1990-07-24 | 1996-01-23 | Polygen Holding Corporation | Polypeptide compounds having growth hormone releasing activity |
US5384253A (en) * | 1990-12-28 | 1995-01-24 | Dekalb Genetics Corporation | Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes |
JPH05507939A (ja) | 1991-04-09 | 1993-11-11 | エフ・ホフマン―ラ ロシユ アーゲー | 成長ホルモン放出因子の類似体 |
WO1993004169A1 (en) * | 1991-08-20 | 1993-03-04 | Genpharm International, Inc. | Gene targeting in animal cells using isogenic dna constructs |
US5663146A (en) | 1991-08-22 | 1997-09-02 | Administrators Of The Tulane Educational Fund | Polypeptide analogues having growth hormone releasing activity |
US5610042A (en) * | 1991-10-07 | 1997-03-11 | Ciba-Geigy Corporation | Methods for stable transformation of wheat |
US5298422A (en) * | 1991-11-06 | 1994-03-29 | Baylor College Of Medicine | Myogenic vector systems |
US5925564A (en) * | 1991-11-06 | 1999-07-20 | Baylor College Of Medicine | Expression vector systems and method of use |
JP3368603B2 (ja) * | 1992-02-28 | 2003-01-20 | オリンパス光学工業株式会社 | 遺伝子治療用処置具 |
US6033884A (en) | 1992-03-20 | 2000-03-07 | Baylor College Of Medicine | Nucleic acid transporter systems and methods of use |
WO1993019768A1 (en) | 1992-04-03 | 1993-10-14 | The Regents Of The University Of California | Self-assembling polynucleotide delivery system |
ATE365209T1 (de) * | 1992-05-14 | 2007-07-15 | Baylor College Medicine | Mutierte steroidhormonrezeptoren, methoden für ihre benutzung und molekularer schalter für gentherapie |
DE69334225D1 (de) * | 1992-07-07 | 2008-07-31 | Japan Tobacco Inc | Verfahren zur transformation einer monokotyledon pflanze |
US5702932A (en) * | 1992-07-20 | 1997-12-30 | University Of Florida | Microinjection methods to transform arthropods with exogenous DNA |
BR9306802A (pt) * | 1992-07-27 | 1998-12-08 | Pioneer Hi Bred Int | Processo independente de genótipos para produção de planta de soja transgénica e processo de regeneração de plantas de soja a partir de nodos cotiledonais |
DE4228457A1 (de) | 1992-08-27 | 1994-04-28 | Beiersdorf Ag | Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen |
GB9222888D0 (en) | 1992-10-30 | 1992-12-16 | British Tech Group | Tomography |
US5439440A (en) * | 1993-04-01 | 1995-08-08 | Genetronics, Inc. | Electroporation system with voltage control feedback for clinical applications |
US5656610A (en) | 1994-06-21 | 1997-08-12 | University Of Southern California | Producing a protein in a mammal by injection of a DNA-sequence into the tongue |
FR2722208B1 (fr) | 1994-07-05 | 1996-10-04 | Inst Nat Sante Rech Med | Nouveau site interne d'entree des ribosomes, vecteur le contenant et utilisation therapeutique |
US5736524A (en) * | 1994-11-14 | 1998-04-07 | Merck & Co.,. Inc. | Polynucleotide tuberculosis vaccine |
US5792747A (en) * | 1995-01-24 | 1998-08-11 | The Administrators Of The Tulane Educational Fund | Highly potent agonists of growth hormone releasing hormone |
AU5441096A (en) * | 1995-04-14 | 1996-10-30 | The Administrators Of The Tulane Eductional Fund | Analogs of growth hormone-releasing factor |
US5780448A (en) | 1995-11-07 | 1998-07-14 | Ottawa Civic Hospital Loeb Research | DNA-based vaccination of fish |
US5928906A (en) | 1996-05-09 | 1999-07-27 | Sequenom, Inc. | Process for direct sequencing during template amplification |
US5945100A (en) | 1996-07-31 | 1999-08-31 | Fbp Corporation | Tumor delivery vehicles |
WO1998006437A2 (en) * | 1996-08-13 | 1998-02-19 | Chiron Corporation | Compositions and methods for polynucleotide delivery |
US5981274A (en) * | 1996-09-18 | 1999-11-09 | Tyrrell; D. Lorne J. | Recombinant hepatitis virus vectors |
US5704908A (en) * | 1996-10-10 | 1998-01-06 | Genetronics, Inc. | Electroporation and iontophoresis catheter with porous balloon |
AU8589998A (en) * | 1997-07-24 | 1999-02-16 | Valentis, Inc. | Ghrh expression system and methods of use |
US5994624A (en) * | 1997-10-20 | 1999-11-30 | Cotton Incorporated | In planta method for the production of transgenic plants |
US6194402B1 (en) * | 1998-09-02 | 2001-02-27 | Merck & Co., Inc. | Enhancement of return to independent living status with a growth hormone secretagogue |
EP1052286A3 (en) * | 1999-04-12 | 2001-07-25 | Pfizer Products Inc. | Growth hormone and growth hormone releasing hormone compositions |
EP1204321B1 (en) | 1999-07-26 | 2005-11-09 | Baylor College Of Medicine | Super-active porcine growth hormone releasing hormone analog |
US7241744B2 (en) * | 2001-12-11 | 2007-07-10 | Baylor College Of Medicine | Treating anemia in subjects by administration of plasmids encoding growth hormone releasing hormone |
US7964196B2 (en) * | 2004-05-25 | 2011-06-21 | Chimeros, Inc. | Self-assembling nanoparticle drug delivery system |
US9302725B2 (en) | 2013-03-14 | 2016-04-05 | Bell Sports, Inc. | Locking rack system for bicycles |
WO2015178959A1 (en) | 2014-05-19 | 2015-11-26 | Felix Sorkin | Modified permanent cap |
-
2002
- 2002-12-10 US US10/315,907 patent/US7241744B2/en not_active Expired - Lifetime
- 2002-12-10 MX MXPA04005713A patent/MXPA04005713A/es not_active Application Discontinuation
- 2002-12-10 WO PCT/US2002/039509 patent/WO2003049700A2/en not_active Application Discontinuation
- 2002-12-10 AU AU2002357143A patent/AU2002357143B2/en not_active Expired
- 2002-12-10 EP EP02804771.0A patent/EP1465654B1/en not_active Expired - Lifetime
- 2002-12-10 MY MYPI20024609A patent/MY142457A/en unknown
- 2002-12-10 CA CA2469310A patent/CA2469310C/en not_active Expired - Lifetime
- 2002-12-10 AR ARP020104785A patent/AR037778A1/es not_active Application Discontinuation
- 2002-12-10 BR BR0214869-2A patent/BR0214869A/pt not_active Application Discontinuation
- 2002-12-10 CN CNA02827105XA patent/CN1615151A/zh active Pending
- 2002-12-10 TW TW091135752A patent/TW200301778A/zh unknown
-
2007
- 2007-03-21 US US11/726,291 patent/US8178504B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AU2002357143B2 (en) | 2009-07-30 |
WO2003049700A2 (en) | 2003-06-19 |
EP1465654B1 (en) | 2015-02-25 |
US8178504B2 (en) | 2012-05-15 |
US7241744B2 (en) | 2007-07-10 |
MXPA04005713A (es) | 2005-06-06 |
WO2003049700A3 (en) | 2003-09-18 |
EP1465654A4 (en) | 2007-08-29 |
CA2469310C (en) | 2013-01-29 |
CA2469310A1 (en) | 2003-06-19 |
US20040057941A1 (en) | 2004-03-25 |
TW200301778A (en) | 2003-07-16 |
MY142457A (en) | 2010-11-30 |
WO2003049700B1 (en) | 2003-10-30 |
US20090170748A1 (en) | 2009-07-02 |
BR0214869A (pt) | 2005-03-08 |
EP1465654A2 (en) | 2004-10-13 |
CN1615151A (zh) | 2005-05-11 |
AU2002357143A1 (en) | 2003-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR037778A1 (es) | Suplementacion mediada por plasmido para el tratamiento de sujetos cronicamente enfermos | |
DE60327786D1 (de) | Kdr-peptide und diese enthaltende impfstoffe | |
EA200400205A1 (ru) | Пептиды, эффективные в лечении опухолей и других заболеваний, требующих удаления или разрушения клеток | |
DK1442058T3 (da) | Peptider der er effektive til behandling af tumorer og andre tilstande der kræver fjernelse eller destruktion af celler | |
EA200800368A1 (ru) | Гликозилированный il-7, получение и применение | |
US3948875A (en) | Process for the preparation of epidermal growth factor and new derivative using cross-linked polyacrylamide gel at a pH of 1-3 | |
ES2507094T3 (es) | Proteína específica del timo | |
Chen et al. | Release kinetics of Tilapia scale collagen I peptides during tryptic hydrolysis | |
ATE430161T1 (de) | Peptid aus hsp70 welches nk zellaktivtät stimuliert und seine verwendung | |
Cordingley | Trematode eggshells: novel protein biopolymers | |
AR037038A1 (es) | Una composicion y metodo para alterar la masa corporal magra y las propiedades oseas en un sujeto | |
DK1201137T3 (da) | Cystein-/glycinrige peptider | |
DK1264599T3 (da) | TNF-afledte peptider til anvendelse i behandling af ödem | |
ATE420191T1 (de) | Promotoren zur expression im modifizierten vacciniavirus ankara | |
FI20050753A0 (fi) | Uudet peptidit | |
AR010337A1 (es) | Acido nucleico aislado, molecula de acido nucleico, sonda, vector de expresion recombinante, celula, metodo para producir un polipeptido de h.pylori, metodo para detectar la presencia de un acido nucleico helicobacter, polipeptido de h.pylori aislado, proteina de fusion, formulacion para vacuna | |
DE602004023827D1 (de) | Ionenkanalaktivität hemmende niedrigmolekulare peptide | |
WO2002094859A3 (en) | Mage-a1 peptides for treating or preventing cancer | |
ATE356145T1 (de) | Polypeptide zur regenerierung des nervensystems | |
KR20170079261A (ko) | 흉터 최소화 상처 재생 촉진용 재조합 폴리펩타이드 및 이를 포함하는 생체 접착 소재 | |
AR045000A1 (es) | Gen y proteina de eimeria , y su uso | |
PE20212072A1 (es) | Composiciones utiles en el tratamiento de la enfermedad de krabbe | |
ATE325812T1 (de) | Menschliches, gebärmutterkrebs-spezifisches suppressorprotein, für das protein kodieres polynukleotid, mit dem polynukleotid transformierte zelle und verfahren zur unterdrückung der proliferation von krebszellen unter verwendung des expressionsvektors | |
AR005771A1 (es) | Polipeptidos con actividad de mutanasa, secuencias de acidos nucleicos que los codifican, construccion de acidos nucleicos, vector de expresionrecombinante, celula huesped recombinante, metodos para producir los polipeptidos, polipeptido hibrido y uso de dichos polipeptidos para preparar | |
EP0361956A3 (en) | Increased expression of small molecular weight recombinant proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |